Lessee, Operating Lease, Liability, to be Paid, Year Three of NovaBridge Biosciences from 31 Dec 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
NovaBridge Biosciences quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2019 to 30 Jun 2025.
  • NovaBridge Biosciences Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2025 was $557,000.
NovaBridge Biosciences quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in CNY history and change rate from 31 Dec 2019 to 30 Jun 2025.
  • NovaBridge Biosciences Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2023 was ¥6,378,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (CNY)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $557,000 30 Jun 2025 6-K 06 Oct 2025 2025 Q2
Q4 2024 $1,069,000 +$171,000 +19% 31 Dec 2024 20-F 03 Apr 2025 2024 FY
Q4 2023 $898,000 +$145,000 +19% 31 Dec 2023 20-F 30 Apr 2024 2023 FY
Q4 2022 $753,000 -$4,473,000 -86% 31 Dec 2022 20-F 01 May 2023 2022 FY
Q4 2021 $5,226,000 +$4,389,000 +524% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $837,000 +$566,000 +209% 31 Dec 2020 20-F 28 Apr 2021 2020 FY
Q4 2019 $271,000 31 Dec 2019 20-F 29 Apr 2020 2019 FY

NovaBridge Biosciences Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 ¥6,378,000 +¥1,185,000 +23% 31 Dec 2023 20-F 30 Apr 2024 2023 FY
Q4 2022 ¥5,193,000 -¥28,112,000 -84% 31 Dec 2022 20-F 01 May 2023 2022 FY
Q4 2021 ¥33,305,000 +¥27,841,000 +510% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 ¥5,464,000 +¥3,579,000 +190% 31 Dec 2020 20-F 28 Apr 2021 2020 FY
Q4 2019 ¥1,885,000 31 Dec 2019 20-F 29 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.